Company: RMSGW
Filing Date: 2025-07-31
Form Type: 20-F
Source: 0001641172-25-021609
Chunk: 74

Company: Real Messenger Corp
Filing Date: 2025-07-31
Form: 20-F
Item: Item 5
Chunk 74
---
 an increase in legal and professional fees in related to the business combination transactions costs with Nova SPAC and
the related listing expenses after the business combination transactions.

  52  

Research
and development expenses

Research
and development expenses primarily consist of staff costs including salaries, social insurance, and housing funds for our personnel in
research and development departments, and other miscellaneous expenses. Our research and development expenses decreased by approximately
$0.6 million, or 43.0% from $1.5 million for the year ended March 31, 2024 to $0.8 million for the year ended March 31, 2025. The decrease
was primarily due to the reductions in headcounts which we closely monitored and controlled the expenditures in the research and development
department.

Net
loss

As
a result of the foregoing, our net loss was approximately $3.4 million and $4.9 million for the years ended March 31, 2025 and 2024,
respectively.

Comparison
of the Years Ended March 31, 2024 and 2023

Operating
expenses

                                                         For                                              Variance                           
                                   the years ended March 31,                                                                                 
                                                        2024                     2023                     Amount                             
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Sales                                                           1,771,614                2,051,550                    (279,936      (13.6  
  General                                                         1,657,879                1,315,509                     342,370       26.0  
  Research                                                        1,459,828                  929,916                     529,912       57.0  
  Total                                                           4,889,321                4,296,975                     592,346       13.8  

Sales
and marketing expenses

Our
sales and marketing expenses decreased by approximately $0.3 million, or 13.6% from $2.1 million for the year ended March 31, 2023 to
$1.8 million for the year ended March 31, 2024. The decrease was mainly due to decreasing expenditure on conference events sponsorship.

General
and administrative expenses

Our
general and administrative expenses increased by approximately $0.3 million, or 26.0% from $1.3 million for the year ended March 31,
2023 to $1.7 million for the year ended March